transparent gif


Ej inloggad.

Göteborgs universitets publikationer

Growth hormone aggravates renal abnormalities induced by neonatal enalapril treatment.

Författare och institution:
Annika B M Nilsson (-); Peter Friberg (Institutionen för fysiologi och farmakologi, Avdelningen för fysiologi); Linda Bönquist (-); Daina Lasaitiene (Institutionen för fysiologi och farmakologi, Avdelningen för fysiologi); Niels Marcussen (-); Yun Chen (Institutionen för fysiologi och farmakologi, Avdelningen för fysiologi)
Publicerad i:
Pediatric nephrology (Berlin, Germany), 18 ( 9 ) s. 878-86
Artikel, refereegranskad vetenskaplig
Sammanfattning (abstract):
Lack of neonatal angiotensin II type-1 receptor stimulation produces irreversible abnormalities of renal function and morphology, which can be prevented by simultaneous administration of insulin-like growth factor-I (IGF-I). Given the fact that growth hormone (GH) is the strongest secretagogue for IGF-I, we wanted to explore whether GH could reproduce the effect of IGF-I. Rats were treated from 3 to 13 days of age with the angiotensin-converting enzyme inhibitor enalapril (10 mg/kg/day) and GH (4 mg/kg/day), alone or in combination. Renal gene expression of IGF-I and IGF-binding proteins (IGFBP) was determined during and after treatment. Renal function and morphology were investigated at adult age. In contrast to the beneficial effect of IGF-I, GH treatment in combination with enalapril further deteriorated both renal function and morphology as compared with enalapril treatment alone, demonstrating: reduced glomerular filtration rate, increased tubular dilation and further expansion of the outer medulla. Enalapril decreased medullary expression of IGF-I and increased renal expression of IGFBP-1, changes that were not affected by concomitant GH treatment. These findings indicate that GH and IGF-I have different roles in the renin-angiotensin system-mediated kidney development.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
Medicinsk bioteknologi ->
Biomedicinsk laboratorievetenskap/teknologi ->
Angiotensin-Converting Enzyme Inhibitors, pharmacology, Animals, Animals, Newborn, Drug Synergism, Enalapril, pharmacology, Gene Expression, drug effects, Glomerular Filtration Rate, drug effects, Human Growth Hormone, pharmacology, Insulin-Like Growth Factor Binding Proteins, blood, genetics, Insulin-Like Growth Factor I, genetics, metabolism, Kidney, growth & development, pathology, physiology, Kidney Concentrating Ability, drug effects, Male, Rats, Rats, Wistar, Renin-Angiotensin System, drug effects
Postens nummer:
Posten skapad:
2012-01-12 15:42

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007